Cargando…
Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions
Adverse drug reactions (ADRs) remain associated with significant mortality. Delayed hypersensitivity reactions (DHRs) that occur greater than 6 h following drug administration are T-cell mediated with many severe DHRs now associated with human leukocyte antigen (HLA) risk alleles, opening pathways f...
Autores principales: | Li, Yueran, Deshpande, Pooja, Hertzman, Rebecca J., Palubinsky, Amy M., Gibson, Andrew, Phillips, Elizabeth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085493/ https://www.ncbi.nlm.nih.gov/pubmed/33936169 http://dx.doi.org/10.3389/fgene.2021.641905 |
Ejemplares similares
-
Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data
por: Hertzman, Rebecca J., et al.
Publicado: (2021) -
A low‐cost, sensitive and specific PCR‐based tool for rapid clinical detection of HLA‐B*35 alleles associated with delayed drug hypersensitivity reactions
por: Li, Yueran, et al.
Publicado: (2022) -
An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
por: Copaescu, Ana, et al.
Publicado: (2021) -
Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
por: Chu, Mu-Tzu, et al.
Publicado: (2023) -
Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2023)